Does concomitant diabetes affect treatment responses in overactive bladder patients?

T. Schneider,D. Marschall‐Kehrel,J. Hanisch,M. Michel
DOI: https://doi.org/10.1111/ijcp.12196
IF: 2.6
2013-11-01
International Journal of Clinical Practice
Abstract:To compare the efficacy and tolerability of a muscarinic receptor antagonist, darifenacin, in the treatment of overactive bladder (OAB) patients with concomitant diabetes as compared with those without comorbidities.
What problem does this paper attempt to address?